We are live on ! Find out more
CF

Corebridge Financial Portfolio holdings

AUM $4.25M
1-Year Est. Return 33.15%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
-33.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.7B
AUM Growth
+$539M
Cap. Flow
-$486M
Cap. Flow %
-2.59%
Top 10 Hldgs %
25.55%
Holding
3,078
New
21
Increased
334
Reduced
2,669
Closed
33

Top Buys

Rank Stock Value
1
AVTR icon
Avantor
AVTR
+$19.6M
2
PLTR icon
Palantir
PLTR
+$15.2M
3
AAPL icon
Apple
AAPL
+$12.8M
4
CNH
CNH Industrial
CNH
+$10.5M
5
WAL icon
Western Alliance Bancorporation
WAL
+$9.86M

Sector Composition

Rank Sector Weight
1 Technology 28.58%
2 Financials 12.72%
3 Healthcare 11.35%
4 Consumer Discretionary 11.12%
5 Industrials 10.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCRX icon
1851
Pacira BioSciences
PCRX
$1.01B
$396K ﹤0.01%
26,316
-296
-1% -$5.06K
TPB icon
1852
Turning Point Brands
TPB
$1.43B
$395K ﹤0.01%
9,164
-57
-0.6% -$2.18K
RPAY icon
1853
Repay Holdings
RPAY
$295M
$395K ﹤0.01%
48,389
-298
-0.6% -$2.63K
CSTL icon
1854
Castle Biosciences
CSTL
$988M
$394K ﹤0.01%
13,832
-85
-0.6% -$2.16K
RGR icon
1855
Sturm, Ruger & Co
RGR
$603M
$394K ﹤0.01%
9,443
-410
-4% -$17.3K
SHEN icon
1856
Shenandoah Telecom
SHEN
$659M
$393K ﹤0.01%
27,845
-471
-2% -$7.78K
EU
1857
enCore Energy
EU
$214M
$392K ﹤0.01%
97,085
+1,194
+1% +$4.42K
FCBC icon
1858
First Community Bankshares
FCBC
$894M
$391K ﹤0.01%
9,062
-156
-2% -$6.51K
HY icon
1859
Hyster-Yale Materials Handling
HY
$603M
$391K ﹤0.01%
6,126
-37
-0.6% -$2.41K
PTLO icon
1860
Portillo's
PTLO
$297M
$389K ﹤0.01%
28,880
-177
-0.6% -$1.98K
ATI icon
1861
ATI
ATI
$27.1B
$389K ﹤0.01%
5,810
-373
-6% -$23.2K
YEXT icon
1862
Yext
YEXT
$633M
$388K ﹤0.01%
56,045
-345
-0.6% -$1.92K
BRSP
1863
BrightSpire Capital
BRSP
$563M
$387K ﹤0.01%
69,071
-426
-0.6% -$2.51K
DAWN
1864
DELISTED
Day One Biopharmaceuticals
DAWN
$387K ﹤0.01%
27,753
-171
-0.6% -$2.44K
NBBK icon
1865
NB Bancorp
NBBK
$999M
$386K ﹤0.01%
20,818
-128
-0.6% -$2.26K
PSFE icon
1866
Paysafe
PSFE
$331M
$386K ﹤0.01%
17,226
-105
-0.6% -$2.18K
CATX icon
1867
Perspective Therapeutics
CATX
$321M
$386K ﹤0.01%
28,905
+3,572
+14% +$47.5K
VIR icon
1868
Vir Biotechnology
VIR
$1.8B
$386K ﹤0.01%
51,477
-361
-0.7% -$3.14K
MLAB icon
1869
Mesa Laboratories
MLAB
$676M
$386K ﹤0.01%
2,969
-19
-0.6% -$2.23K
PUMP icon
1870
ProPetro Holding
PUMP
$1.41B
$385K ﹤0.01%
50,314
-1,987
-4% -$16.2K
HLF icon
1871
Herbalife
HLF
$1.26B
$384K ﹤0.01%
53,433
-329
-0.6% -$3.03K
EGBN icon
1872
Eagle Bancorp
EGBN
$841M
$383K ﹤0.01%
16,977
-181
-1% -$3.8K
DXPE icon
1873
DXP Enterprises
DXPE
$2.9B
$383K ﹤0.01%
7,178
-86
-1% -$4.32K
CTKB icon
1874
Cytek Biosciences
CTKB
$599M
$383K ﹤0.01%
69,084
-246
-0.4% -$1.4K
KELYA icon
1875
Kelly Services Class A
KELYA
$552M
$382K ﹤0.01%
17,834
-189
-1% -$4.01K

Similar funds

Corebridge Financial's Q3 2024 Portfolio in Review

As of Q3 2024, Corebridge Financial held 3,078 positions worth $18.7B, up 3% from $18.2B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 1.8%. Corebridge Financial opened 21 new positions and exited 33, leaving the 3,078-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.

  • Corebridge Financial's largest Q3 2024 buy was Dell: 70,274 shares worth $8.33M.
  • Corebridge Financial added most to Avantor in Q3 2024, an estimated $19.6M increase.
  • Corebridge Financial's biggest Q3 2024 reduction was Microsoft, cutting an estimated $29.5M.
  • Corebridge Financial fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $10.1M.
  • Corebridge Financial's ten largest holdings make up 26% of its $18.7B portfolio in Q3 2024.
  • Corebridge Financial opened 21 new positions and closed 33 in Q3 2024.
  • Corebridge Financial's portfolio value rose 3% quarter-over-quarter to $18.7B.

Based on Corebridge Financial's 13F filing for Q3 2024, filed 13 Nov 2024.